Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
153,881,229
-
Number of holders
-
92
-
Total 13F shares, excl. options
-
37,121,626
-
Shares change
-
-3,027,451
-
Total reported value, excl. options
-
$90,180,708
-
Value change
-
-$28,161,740
-
Put/Call ratio
-
1.22%
-
Number of buys
-
44
-
Number of sells
-
-60
-
Price
-
$2.43
Significant Holders of Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) as of Q2 2023
126 filings reported holding ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 as of Q2 2023.
Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) has 92 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37,121,626 shares
of 153,881,229 outstanding shares and own 24.12% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (8,322,140 shares), RTW INVESTMENTS, LP (4,241,472 shares), COWEN AND COMPANY, LLC (2,834,864 shares), TANG CAPITAL MANAGEMENT LLC (2,479,552 shares), MORGAN STANLEY (2,447,843 shares), BlackRock Inc. (2,387,712 shares), Carlyle Group Inc. (2,115,385 shares), VANGUARD GROUP INC (1,668,686 shares), DEUTSCHE BANK AG\ (1,021,103 shares), and DAFNA Capital Management LLC (797,054 shares).
This table shows the top 92 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.